Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acthar in Rheumatoid Arthritis Related Flares
NCT02541955Phase 4Completed
- Start
- Jul 2017
- Primary completion
- May 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of repository corticotropin injection in rheumatoid arthritis (RA) (2 arms). Primary endpoints: Disease Activity Score 28 at 4 weeks and Power Doppler Ultrasound Score at 4 weeks. Started Jul 2017; status: completed.
02
Drugs
repository corticotropin injection
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02541955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02541955.